Respiratory Infections News

In a first, the FDA today approved the Pfizer-BioNTech COVID-19 vaccine for people aged 16 years or older.

Pooled estimates from a systematic review of nearly 40 studies found that only around half of migrants with latent tuberculosis infection initiated and completed treatment, according to findings reported in The Lancet Infectious Diseases.

The FDA granted Paratek Pharmaceuticals orphan drug designation for Nuzyra to treat infections caused by nontuberculous mycobacteria, the company announced this week.

The United States will begin offering third doses of COVID-19 vaccine to fully vaccinated Americans beginning Sept. 20, Biden administration officials announced Wednesday.

The Biden administration is poised to recommend as early as this week that most Americans should get a booster shot of COVID-19 vaccine 8 months after completing an initial two-dose series, according to multiple reports.

Women with COVID-19 during the pandemic’s second wave in India had higher rates of severe disease, admissions to the ICU or high dependency unit and maternal deaths compared with the first wave, findings show.

Dexamethasone, “an evidence-based treatment” for COVID-19, might have been “underused” among patients with the condition who required ventilation, researchers of a retrospective study wrote.

SARS-CoV-2 infection during pregnancy was associated with higher odds of preeclampsia, and this relationship may be causal, according to a study published by the American Journal of Obstetrics and Gynecology.

Previous SARS-CoV-2 exposure increased the odds of developing clinically significant symptoms following the first dose of a COVID-19 mRNA vaccine, researchers reported in JAMA Internal Medicine.

Women diagnosed with COVID-19 while pregnant, particularly those with other comorbidities, had a higher risk for very preterm birth, preterm birth and early-term birth, a population-based study showed.